• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

不同变异型埃博拉病毒和马尔堡病毒的气溶胶稳定性比较及免疫缺陷小鼠中气溶胶化埃博拉病毒的毒力。

Comparison of Aerosol Stability of Different Variants of Ebola Virus and Marburg Virus and Virulence of Aerosolised Ebola Virus in an Immune-Deficient Mouse.

机构信息

Microbiology and Aerosol Sciences Group, CBR Division, Defence Science and Technology Laboratory (Dstl), Porton Down, Wiltshire, Salisbury SP4 0JQ, UK.

出版信息

Viruses. 2022 Apr 9;14(4):780. doi: 10.3390/v14040780.

DOI:10.3390/v14040780
PMID:35458510
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9030064/
Abstract

During outbreaks of virus diseases, many variants may appear, some of which may be of concern. Stability in an aerosol of several Ebola virus and Marburg virus variants was investigated. Studies were performed measuring aerosol survival using the Goldberg drum but no significant difference in biological decay rates between variants was observed. In addition, historic data on virulence in a murine model of different Ebola virus variants were compared to newly presented data for Ebola virus Kikwit in the A129 Interferon alpha/beta receptor-deficient mouse model. Ebola virus Kikwit was less virulent than Ebola virus Ecran in our mouse model. The mouse model may be a useful tool for studying differences in virulence associated with different variants whereas aerosol stability studies may not need to be conducted beyond the species level.

摘要

在病毒疾病爆发期间,可能会出现许多变体,其中一些可能引起关注。本研究调查了几种埃博拉病毒和马尔堡病毒变体在气溶胶中的稳定性。使用 Goldberg 滚筒测量气溶胶存活时间的研究表明,变体之间的生物衰减率没有显著差异。此外,还将不同埃博拉病毒变体在鼠模型中的毒力的历史数据与新提出的埃博拉病毒基奎特在 A129 干扰素 α/β受体缺陷型鼠模型中的数据进行了比较。在我们的鼠模型中,埃博拉病毒基奎特的毒力低于埃博拉病毒 Ecran。鼠模型可能是研究与不同变体相关的毒力差异的有用工具,而气溶胶稳定性研究可能不需要在种属水平以上进行。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c69a/9030064/d02a1e1c5910/viruses-14-00780-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c69a/9030064/d31a392a9c7d/viruses-14-00780-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c69a/9030064/20170ba6bf13/viruses-14-00780-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c69a/9030064/d02a1e1c5910/viruses-14-00780-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c69a/9030064/d31a392a9c7d/viruses-14-00780-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c69a/9030064/20170ba6bf13/viruses-14-00780-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c69a/9030064/d02a1e1c5910/viruses-14-00780-g003.jpg

相似文献

1
Comparison of Aerosol Stability of Different Variants of Ebola Virus and Marburg Virus and Virulence of Aerosolised Ebola Virus in an Immune-Deficient Mouse.不同变异型埃博拉病毒和马尔堡病毒的气溶胶稳定性比较及免疫缺陷小鼠中气溶胶化埃博拉病毒的毒力。
Viruses. 2022 Apr 9;14(4):780. doi: 10.3390/v14040780.
2
Lethality and pathogenesis of airborne infection with filoviruses in A129 α/β -/- interferon receptor-deficient mice.空气传播病毒感染 A129 α/β -/- 干扰素受体缺陷型小鼠的致死性和发病机制。
J Med Microbiol. 2012 Jan;61(Pt 1):8-15. doi: 10.1099/jmm.0.036210-0. Epub 2011 Aug 18.
3
Filovirus Virulence in Interferon α/β and γ Double Knockout Mice, and Treatment with Favipiravir.丝状病毒在干扰素 α/β 和 γ 双敲除小鼠中的毒力,以及用法匹拉韦治疗。
Viruses. 2019 Feb 3;11(2):137. doi: 10.3390/v11020137.
4
Single-Dose Trivalent VesiculoVax Vaccine Protects Macaques from Lethal Ebolavirus and Marburgvirus Challenge.单价三价囊泡疫苗可保护猕猴免受致命埃博拉病毒和马尔堡病毒的挑战。
J Virol. 2018 Jan 17;92(3). doi: 10.1128/JVI.01190-17. Print 2018 Feb 1.
5
Marburg and Ebola viruses as aerosol threats.作为气溶胶威胁的马尔堡病毒和埃博拉病毒。
Biosecur Bioterror. 2004;2(3):186-91. doi: 10.1089/bsp.2004.2.186.
6
[Marburg and Ebola hemorrhagic fevers--pathogens, epidemiology and therapy].[马尔堡出血热和埃博拉出血热——病原体、流行病学与治疗]
Med Monatsschr Pharm. 2014 Sep;37(9):324-30; quiz 331-2.
7
Emerging diseases. On the trail of Ebola and Marburg viruses.新发疾病。追踪埃博拉病毒和马尔堡病毒。
Science. 2000 Nov 3;290(5493):923-5. doi: 10.1126/science.290.5493.923.
8
Vaccines against Ebola virus and Marburg virus: recent advances and promising candidates.埃博拉病毒和马尔堡病毒疫苗:最新进展和有前途的候选疫苗。
Hum Vaccin Immunother. 2019;15(10):2359-2377. doi: 10.1080/21645515.2019.1651140. Epub 2019 Oct 7.
9
Interferon-β therapy prolongs survival in rhesus macaque models of Ebola and Marburg hemorrhagic fever.干扰素-β 疗法延长了埃博拉和马尔堡出血热恒河猴模型的存活时间。
J Infect Dis. 2013 Jul 15;208(2):310-8. doi: 10.1093/infdis/jis921. Epub 2012 Dec 18.
10
Sequencing ebola and marburg viruses genomes using microarrays.使用微阵列对埃博拉和马尔堡病毒基因组进行测序。
J Med Virol. 2016 Aug;88(8):1303-8. doi: 10.1002/jmv.24487. Epub 2016 Feb 8.

引用本文的文献

1
A Small-Particle Aerosol Model of Ebolavirus Zaire Infection in Ferrets.雪貂感染扎伊尔埃博拉病毒的小颗粒气溶胶模型
Viruses. 2024 Nov 21;16(12):1806. doi: 10.3390/v16121806.
2
How long do bacteria, fungi, protozoa, and viruses retain their replication capacity on inanimate surfaces? A systematic review examining environmental resilience versus healthcare-associated infection risk by "fomite-borne risk assessment".细菌、真菌、原生动物和病毒在无生命表面保持其复制能力的时间有多长?一项通过“污染物传播风险评估”研究环境恢复力与医疗保健相关感染风险的系统综述。
Clin Microbiol Rev. 2024 Dec 10;37(4):e0018623. doi: 10.1128/cmr.00186-23. Epub 2024 Oct 10.
3

本文引用的文献

1
Guinea reports west Africa's first ever case of Marburg virus disease.几内亚报告了西非首例马尔堡病毒病病例。
BMJ. 2021 Aug 10;374:n1988. doi: 10.1136/bmj.n1988.
2
Characteristics of SARS-CoV-2 variants of concern B.1.1.7, B.1.351 or P.1: data from seven EU/EEA countries, weeks 38/2020 to 10/2021.关注的 SARS-CoV-2 变体 B.1.1.7、B.1.351 或 P.1 的特征:来自七个欧盟/欧洲经济区国家的数据,2020 年第 38 周至 2021 年第 10 周。
Euro Surveill. 2021 Apr;26(16). doi: 10.2807/1560-7917.ES.2021.26.16.2100348.
3
The Stability of an Isolate of the SARS-CoV-2 B.1.1.7 Lineage in Aerosols Is Similar to 3 Earlier Isolates.
Recent Advances in Crimean-Congo Hemorrhagic Fever Virus Detection, Treatment, and Vaccination: Overview of Current Status and Challenges.
克里米亚-刚果出血热病毒检测、治疗及疫苗接种的最新进展:现状与挑战概述
Biol Proced Online. 2024 Jun 26;26(1):20. doi: 10.1186/s12575-024-00244-3.
4
Aerosol Survival, Disinfection and Formalin Inactivation of Nipah Virus.尼帕病毒气溶胶存活、消毒和福尔马林失活。
Viruses. 2022 Sep 16;14(9):2057. doi: 10.3390/v14092057.
新冠病毒 B.1.1.7 谱系分离株在气溶胶中的稳定性与 3 个早期分离株相似。
J Infect Dis. 2021 Nov 22;224(10):1641-1648. doi: 10.1093/infdis/jiab171.
4
The variant gambit: COVID-19's next move.变异策略:新冠病毒的下一步行动。
Cell Host Microbe. 2021 Apr 14;29(4):508-515. doi: 10.1016/j.chom.2021.02.020. Epub 2021 Mar 1.
5
Ebola and COVID-19 in DR Congo and Guinea.刚果民主共和国和几内亚的埃博拉疫情与新冠疫情。
Lancet Infect Dis. 2021 Apr;21(4):461. doi: 10.1016/S1473-3099(21)00155-9.
6
Transmissibility and transmission of respiratory viruses.呼吸道病毒的传播力和传播。
Nat Rev Microbiol. 2021 Aug;19(8):528-545. doi: 10.1038/s41579-021-00535-6. Epub 2021 Mar 22.
7
Pathogenicity and Virulence of Ebolaviruses with Species- and Variant-specificity.埃博拉病毒的物种和变体特异性的致病性和毒力。
Virulence. 2021 Dec;12(1):885-901. doi: 10.1080/21505594.2021.1898169.
8
Survival of Lassa Virus in Blood and Tissue Culture Media and in a Small Particle Aerosol.拉沙病毒在血液、组织培养基及小颗粒气溶胶中的存活情况。
Pathogens. 2020 Aug 21;9(9):680. doi: 10.3390/pathogens9090680.
9
Experimental aerosol survival of SARS-CoV-2 in artificial saliva and tissue culture media at medium and high humidity.在中高湿度下,人工唾液和组织培养液中 SARS-CoV-2 的实验气溶胶存活情况。
Emerg Microbes Infect. 2020 Dec;9(1):1415-1417. doi: 10.1080/22221751.2020.1777906.
10
The Epidemiological Presentation Pattern of Ebola Virus Disease Outbreaks: Changes from 1976 to 2019.埃博拉病毒病疫情的流行病学表现模式:1976 年至 2019 年的变化。
Prehosp Disaster Med. 2020 Jun;35(3):247-253. doi: 10.1017/S1049023X20000333. Epub 2020 Mar 18.